Lastacaft
Product Images NDC 42254-288

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lastacaft (NDC 42254-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (4b8c6afe 2d76 46c7 A23e 99db5e180ff6 01)

Chemical structure of the active ingredient in LASTACAFT, showing a complex bicyclic and heterocyclic molecular framework with a formyl group attached to a pyrazole ring and a methyl-substituted piperidine moiety.*

FDA Label Image

Lastacaft 0.25% (4b8c6afe 2d76 46c7 A23e 99db5e180ff6 02)

The label for Lastacaft 0.25% 3ml Alcaftadine Ophthalmic Solution by Rebel Distributors Corp (NDC 42254-288-03) is shown. It states each 3ml bottle contains 0.25% Alcaftadine (2.5mg/ml). The label is marked RX Only and includes storage instructions at 15-30°C (59-86°F) and a warning to keep out of reach of children. The manufacturer is JHP Pharmaceuticals, LLC, Rochester, MI.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.